Lincoln Pharma.

{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "478.50",
    "chg": 12.75,
    "chgp": "2.74%",
    "dir": 1,
    "prev_price": "465.75",
    "mcapval": "970.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "17.76 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3817715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LincolnPharmace_mojoScore_3817715.png",
        "date": "2026-02-03 10:14:03",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs43995-3807601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3807601.png",
        "date": "2026-01-28 10:41:39",
        "description": "Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics."
      },
      {
        "title": "Why is Lincoln Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharmaceuticals-ltd-fallingrising-3806575",
        "imagepath": "",
        "date": "2026-01-28 00:42:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movements and Intraday Volatility</strong></p>\n<p>On the trading day of 27 January, Lincoln Pharmaceuticals experienced notable intraday fluctuations. The stock touched an intraday low of ₹442.85, representing a decline of 2.28% from previous levels and setting a fresh 52-week low. However, by the market close, the price rebounded to ₹460.00, up ₹6.80 or 1.5% from the prior close. This late-session recovery allowed the stock to outperform its sector by 1.83%, signalling some renewed buying interest despite the earlier weakness.</p>\n<p><strong>Comparative Performance Against Benchmarks</strong></p>\n<p>Examining Lincoln Pharmaceuticals’ returns relative to the broader market and benchmarks reveals a mixed picture. Over the past week, the stock declined marginally by 0.33%, slightl..."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs-44285-3806342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3806342.png",
        "date": "2026-01-27 15:42:42",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3801384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_mojoScore_3801384.png",
        "date": "2026-01-23 10:10:54",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs45305-3798669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3798669.png",
        "date": "2026-01-21 11:51:57",
        "description": "Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs45455-3796075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3796075.png",
        "date": "2026-01-20 10:24:21",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs46525-3794456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3794456.png",
        "date": "2026-01-19 10:32:18",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3789708",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_mojoScore_3789708.png",
        "date": "2026-01-12 10:10:38",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 939,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "10-Jan-2026",
      "details": "Update on Credit Rating.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-02-03 10:14:03

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95

2026-01-28 10:41:39

Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Read full news article

Why is Lincoln Pharmaceuticals Ltd falling/rising?

2026-01-28 00:42:28

Recent Price Movements and Intraday Volatility

On the trading day of 27 January, Lincoln Pharmaceuticals experienced notable intraday fluctuations. The stock touched an intraday low of ₹442.85, representing a decline of 2.28% from previous levels and setting a fresh 52-week low. However, by the market close, the price rebounded to ₹460.00, up ₹6.80 or 1.5% from the prior close. This late-session recovery allowed the stock to outperform its sector by 1.83%, signalling some renewed buying interest despite the earlier weakness.

Comparative Performance Against Benchmarks

Examining Lincoln Pharmaceuticals’ returns relative to the broader market and benchmarks reveals a mixed picture. Over the past week, the stock declined marginally by 0.33%, slightl...

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85

2026-01-27 15:42:42

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-01-23 10:10:54

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05

2026-01-21 11:51:57

Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment.

Read full news article

Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55

2026-01-20 10:24:21

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25

2026-01-19 10:32:18

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-01-12 10:10:38

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News